InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by McClurg Ronald W., Chief Financial Officer. Insider active across 1 companies, notably NEUROONE MEDICAL TECHNOLOGIES Corp. In total, 5 filings have been logged. Total volume traded: €38k. The latest transaction was disclosed on 15 June 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations5 total
€9,77310,000 shares@ €0.97730.022% mcap25.9% of flow
Common Stock
SEC:0001837830-22-000004:0·
Ideal exit: 12 Mar 2023 (T+270)
€13,91914,000 shares@ €0.99420.031% mcap36.8% of flow
Common Stock
SEC:0001837830-22-000003:0·
Ideal exit: 7 Mar 2023 (T+270)
€14,10717,500 shares@ €0.80610.032% mcap37.3% of flow
Common Stock
SEC:0001837830-22-000002:0·
Ideal exit: 14 Feb 2023 (T+270)
015,000 shares0
Common Stock
SEC:0001837830-22-000001·
015,000 shares0
Common Stock
SEC:0001837830-22-000001:0·
5 of 5 declarations
About McClurg Ronald W.
Ronald W. McClurg is the Chief Financial Officer of NeuroOne Medical Technologies Corp. He is responsible for the company's financial management, including budgeting and risk management. With a strong background in finance, he plays a key role in the financial strategy and performance of the company.
